These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 22711753)

  • 1. Circulating levels of secretory- and lipoprotein-associated phospholipase A2 activities: relation to atherosclerotic plaques and future all-cause mortality.
    Lind L; Simon T; Johansson L; Kotti S; Hansen T; Machecourt J; Ninio E; Tedgui A; Danchin N; Ahlström H; Mallat Z
    Eur Heart J; 2012 Dec; 33(23):2946-54. PubMed ID: 22711753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipoprotein-Associated Phospholipase A2 and Risk of Carotid Atherosclerosis and Cardiovascular Events in Community-Based Older Adults in China.
    Wang C; Fang X; Hua Y; Liu Y; Zhang Z; Gu X; Wu X; Tang Z; Guan S; Liu H; Liu B; Guo X; Ji X
    Angiology; 2018 Jan; 69(1):49-58. PubMed ID: 28429599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Community-based statins and advanced carotid plaque: Role of CD163 positive macrophages in lipoprotein-associated phospholipase A
    Otsuka F; Zhao X; Trout HH; Qiao Y; Wasserman BA; Nakano M; Macphee CH; Brandt M; Krug-Gourley S; Guo L; Ladich ER; Cheng Q; Davis HR; Finn AV; Virmani R; Kolodgie FD
    Atherosclerosis; 2017 Dec; 267():78-89. PubMed ID: 29101839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum lipoprotein-associated phospholipase A2 predicts the formation of carotid artery plaque and its vulnerability in anterior circulation cerebral infarction.
    Yang Y; Xue T; Zhu J; Xu J; Hu X; Wang P; Kong T; Yan Y; Yang L; Xue S
    Clin Neurol Neurosurg; 2017 Sep; 160():40-45. PubMed ID: 28644968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Changes of serum lipoprotein-related phospholipase A2 in patients with white matter lesion based on KIM classification and its correlation with carotid atherosclerotic plaque].
    Zhang W; Zhang YM; Li LL; Xia Y; Zhou X; Zhu XQ; Sun ZW
    Zhonghua Yi Xue Za Zhi; 2020 Apr; 100(15):1130-1135. PubMed ID: 32311875
    [No Abstract]   [Full Text] [Related]  

  • 6. Association of Serum Lipoprotein-Associated Phospholipase A2 and A379V Gene Polymorphisms with Carotid Plaques.
    Wu C; Zhou T; Zhou Y; Han W
    Genet Test Mol Biomarkers; 2020 Mar; 24(3):131-137. PubMed ID: 32109154
    [No Abstract]   [Full Text] [Related]  

  • 7. Evidence supporting a key role of Lp-PLA2-generated lysophosphatidylcholine in human atherosclerotic plaque inflammation.
    Gonçalves I; Edsfeldt A; Ko NY; Grufman H; Berg K; Björkbacka H; Nitulescu M; Persson A; Nilsson M; Prehn C; Adamski J; Nilsson J
    Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1505-12. PubMed ID: 22499993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Danlou Tablet Fought against Inflammatory Reaction in Atherosclerosis Rats with Intermingled Phlegm and Blood Stasis Syndrome and Its Mechanism Study].
    Chen J; Cai HW; Miao J; Xu XM; Mao W
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2016 Jun; 36(6):703-8. PubMed ID: 27491230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipoprotein-associated phospholipase A2 and prognosis after myocardial infarction in the community.
    Gerber Y; McConnell JP; Jaffe AS; Weston SA; Killian JM; Roger VL
    Arterioscler Thromb Vasc Biol; 2006 Nov; 26(11):2517-22. PubMed ID: 16902161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between high-sensitivity C-reactive protein, lipoprotein-associated phospholipase A2 and carotid atherosclerosis: A cross-sectional study.
    Liu H; Yao Y; Wang Y; Ji L; Zhu K; Hu H; Chen J; Yang J; Cui Q; Geng B; Liu Q; Li D; Zhou Y
    J Cell Mol Med; 2018 Oct; 22(10):5145-5150. PubMed ID: 30094934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoprotein-associated phospholipase A2 and risk of incident cardiovascular disease in a multi-ethnic cohort: The multi ethnic study of atherosclerosis.
    Garg PK; McClelland RL; Jenny NS; Criqui MH; Greenland P; Rosenson RS; Siscovick DS; Jorgensen N; Cushman M
    Atherosclerosis; 2015 Jul; 241(1):176-82. PubMed ID: 26004387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipoprotein-associated phospholipase A2 is related to risk of subclinical atherosclerosis but is not supported by Mendelian randomization analysis in a general Japanese population.
    Ueshima H; Kadowaki T; Hisamatsu T; Fujiyoshi A; Miura K; Ohkubo T; Sekikawa A; Kadota A; Kadowaki S; Nakamura Y; Miyagawa N; Okamura T; Kita Y; Takashima N; Kashiwagi A; Maegawa H; Horie M; Yamamoto T; Kimura T; Kita T;
    Atherosclerosis; 2016 Mar; 246():141-7. PubMed ID: 26775119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipoprotein-associated phospholipase A2 and its association with cardiovascular outcomes in patients with acute coronary syndromes in the PROVE IT-TIMI 22 (PRavastatin Or atorVastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction) trial.
    O'Donoghue M; Morrow DA; Sabatine MS; Murphy SA; McCabe CH; Cannon CP; Braunwald E
    Circulation; 2006 Apr; 113(14):1745-52. PubMed ID: 16537575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of lipoprotein-associated phospholipase A(2) in carotid artery plaques predicts long-term cardiac outcome.
    Herrmann J; Mannheim D; Wohlert C; Versari D; Meyer FB; McConnell JP; Gössl M; Lerman LO; Lerman A
    Eur Heart J; 2009 Dec; 30(23):2930-8. PubMed ID: 19689974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LIPOPROTEIN ASSOCIATED PHOSPHOLIPASE A2 AS A MARKER OF VULNERABLE ATHEROSCLEROTIC PLAQUE IN PATIENTS WITH INTERNAL CAROTID ARTERY STENOSIS.
    Štefanič P; Kopolovets I; Hertelyová Z; Tóth Š; Frankovičová M
    Georgian Med News; 2017 Jun; (267):27-34. PubMed ID: 28726649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipoprotein-associated phospholipase A2 independently predicts the angiographic diagnosis of coronary artery disease and coronary death.
    May HT; Horne BD; Anderson JL; Wolfert RL; Muhlestein JB; Renlund DG; Clarke JL; Kolek MJ; Bair TL; Pearson RR; Sudhir K; Carlquist JF
    Am Heart J; 2006 Nov; 152(5):997-1003. PubMed ID: 17070179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between the lipoprotein-associated phospholipase A2 activity and the progression of subclinical atherosclerosis.
    Liu J; Wang W; Qi Y; Yong Q; Zhou G; Wang M; Sun J; Liu J; Jia Z; Zhao D
    J Atheroscler Thromb; 2014; 21(6):532-42. PubMed ID: 24492522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phospholipase A2 is an Inflammatory Predictor in Cardiovascular Diseases: Is there any Spacious Room to Prove the Causation?
    Santoso A; Heriansyah T; Rohman MS
    Curr Cardiol Rev; 2020; 16(1):3-10. PubMed ID: 31146670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Admission lipoprotein-associated phospholipase A2 activity is not associated with long-term clinical outcomes after ST-segment elevation myocardial infarction.
    Woudstra P; Damman P; Kuijt WJ; Kikkert WJ; Grundeken MJ; van Brussel PM; Stroobants AK; van Straalen JP; Fischer JC; Koch KT; Henriques JP; Piek JJ; Tijssen JG; de Winter RJ
    PLoS One; 2014; 9(5):e96251. PubMed ID: 24788873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma lipoprotein-associated phospholipase A2 mass is elevated in STEMI compared to non-STEMI patients but does not discriminate between myocardial infarction and non-cardiac chest pain.
    Dullaart RP; van Pelt LJ; Kwakernaak AJ; Dikkeschei BD; van der Horst IC; Tio RA
    Clin Chim Acta; 2013 Sep; 424():136-40. PubMed ID: 23756128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.